These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 558637)

  • 81. Rabbit lung microsomes: a rapid method for assaying simultaneously drug effects on thromboxane and prostacyclin synthesis.
    Ahnfelt-Rønne I; Arrigoni-Martelli E
    Agents Actions Suppl; 1979; (4):110-9. PubMed ID: 386739
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
    Ku EC; McPherson SE; Signor C; Chertock H; Cash WD
    Biochem Biophys Res Commun; 1983 May; 112(3):899-906. PubMed ID: 6687803
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.
    Nishizawa EE; Williams DJ; Connell CL
    Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Purification of thromboxane synthetase and evidence of two distinct mechanisms for the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid by porcine lung microsomes.
    Hall ER; Tai HH
    Biochim Biophys Acta; 1981 Sep; 665(3):498-503. PubMed ID: 7197552
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
    J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Thromboxane synthesis in hypercholesterolemic platelets--on the mechanism of increased thromboxane synthesis.
    Kawaguchi H
    Hokkaido Igaku Zasshi; 1983 May; 58(3):292-309. PubMed ID: 6618425
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Role of thromboxanes and prostaglandin endoperoxides in the pathogenesis of eicosanoid induced sudden death.
    Lefer AM; Burke SE; Smith JB
    Thromb Res; 1983 Nov; 32(3):311-20. PubMed ID: 6419378
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
    Kuzuya T; Hoshida S; Yamagishi M; Ohmori M; Inoue M; Kamada T; Tada M
    Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR; Maxey KM; Bundy GL
    Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
    [No Abstract]   [Full Text] [Related]  

  • 90. Antiaggregatory effects of thromboxane receptor antagonists in vivo.
    Darius H; Lefer AM
    Thromb Res; 1985 Dec; 40(5):663-75. PubMed ID: 2935972
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Metabolism of arachidonic acid and its endoperoxide (PGH2) to myotropic products in guinea-pig and rabbit isolated lungs.
    Alabaster VA
    Br J Pharmacol; 1980 Jul; 69(3):479-89. PubMed ID: 7397457
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Biologically active derivatives of fatty acids: prostaglandins, thromboxanes, and endoperoxides.
    Kuehl FA; Humes JL; Beveridge GC; Van Arman CG; Egan RW
    Inflammation; 1977 Dec; 2(4):285-94. PubMed ID: 370001
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Differential separation of thromboxanes from prostaglandins by one and two-dimensional thin layer chromatography.
    Bailey JM; Bryant RW; Feinmark SJ; Makheja AN
    Prostaglandins; 1977 Mar; 13(3):479-92. PubMed ID: 847246
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Peroxidase-dependent deactivation of prostacyclin synthetase.
    Ham EA; Egan RW; Soderman DD; Gale PH; Kuehl FA
    J Biol Chem; 1979 Apr; 254(7):2191-4. PubMed ID: 372178
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synthesis of prostaglandin 6-keto F1alpha by cultured aortic smooth muscle cells and stimulation of its formation in a coupled system with platelet lysates.
    Tansik RL; Namm DH; White HL
    Prostaglandins; 1978 Mar; 15(3):399-408. PubMed ID: 663276
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Electron capture gas chromatographic detection of thromboxane B2.
    Fitzpatrick FA; Gorman RR; Wynalda MA
    Prostaglandins; 1977 Feb; 13(2):201-8. PubMed ID: 847227
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dipyridamole: a possible potent inhibitor of thromboxane A2 synthetase in vascular smooth muscle.
    Ally AI; Manku MS; Horrobin DF; Morgan RO; Karmazin M; Karmali RA
    Prostaglandins; 1977 Sep; 14(3):607-9. PubMed ID: 905584
    [No Abstract]   [Full Text] [Related]  

  • 99. The effect of imidazole-analogues on bone resorption in vitro: a suggested role for thromboxane A2.
    Heersche JN; Jez DH
    Prostaglandins; 1981 Mar; 21(3):401-11. PubMed ID: 7232765
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The identification of two novel prostaglandins and a thromboxane.
    Cockerill AF; Mallen DN; Osborne DJ; Boot JR; Dawson W
    Prostaglandins; 1977 Jun; 13(6):1033-43. PubMed ID: 887794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.